Monday, April 02, 2012
Wednesday, March 28, 2012
Tuesday, March 27, 2012
-
JP Morgan on MAP Pharmaceuticals Delayed Approval of Levadex (Analyst Color, CRL, MAPP, News, Reiteration, FDA, Analyst Ratings / Tue, 07:49am)
Wednesday, January 04, 2012
-
JP Morgan Reiterates BioMimetic Therapeutics Neutral (Analyst Color, BMTI, CRL, Price Target, Reiteration, Analyst Ratings / Wed, 02:05pm)
Thursday, December 15, 2011
Wednesday, December 14, 2011
Monday, December 05, 2011
Monday, November 28, 2011
Tuesday, November 15, 2011
Monday, November 14, 2011
Wednesday, September 28, 2011
Wednesday, August 24, 2011
-
Jefferies Has Hold On Charles River Laboratories (Analyst Color, CRL, Price Target, Analyst Ratings / Wed, 07:36am)
Tuesday, August 09, 2011
-
Jefferies Lowers PT On Charles River Laboratories To $33 (CRL, Price Target, Analyst Ratings / Tue, 06:26am)
Thursday, August 04, 2011
Wednesday, July 20, 2011
-
Jefferies Reports FDA Votes Against BMY Dapagliflozin Approval (Analyst Color, BMY, CRL, Analyst Ratings / Wed, 07:47am)
Thursday, May 05, 2011
-
Jefferies Raises PT On Charles River Laboratories To $44 (CRL, Price Target, Analyst Ratings / Thu, 09:05am)
Wednesday, May 04, 2011
-
JP Morgan Raises PT On Charles River Laboratories To $38 (CRL, Price Target, Analyst Ratings / Wed, 06:42am)
Thursday, February 17, 2011
-
Deutsche Bank Reiterates Hold On XenoPort (XNPT) (Analyst Color, CRL, XNPT, Price Target, Analyst Ratings / Thu, 08:16am)
Thursday, February 10, 2011
-
Wells Fargo Raises CRL Valuation Range To $44-$45 from $42-$43 (CRL, Analyst Ratings / Thu, 11:00am)
-
Jefferies Raises PT On Charles River Laboratories To $40 (CRL, Price Target, Analyst Ratings / Thu, 09:09am)
Wednesday, February 09, 2011
-
CRL Revenue Exceeds Jefferies Estimate By $3.6M (CRL, Analyst Ratings / Wed, 10:23am)
Tuesday, January 25, 2011
-
Jefferies Pharmaceuticals Update (CRL, PPDI, WX) (Analyst Color, CRL, PPDI, WX, Analyst Ratings / Tue, 09:17am)
Monday, January 10, 2011
-
Oppenheimer Maintains ENDP Rating, Estimates And PT (CRL, ENDP, Analyst Ratings / Mon, 08:48am)
Tuesday, December 28, 2010
-
Alimera Sciences: Iluvien Approval Delayed By FDA (ALIM, Analyst Color, CRL, Price Target, FDA, Analyst Ratings / Tue, 08:34am)
Monday, December 27, 2010
-
A Peek Into The Market Before The Trading Starts (ALIM, Analyst Color, CALM, CPHD, CRL, DDAIF, DRRX, Earnings, KG, Long Ideas, MHR, News, NGAS, PTIE, VLKAY, Futures, Short Ideas, Price Target, FDA, M&A, Global, Pre-Market Outlook, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 09:06am)
Thursday, December 23, 2010
-
Hapoaliom Views Arena's Lorcaserin As Unapprovable (Analyst Color, ARNA, CRL, FDA, Analyst Ratings / Thu, 10:12am)
Tuesday, December 14, 2010
Friday, December 10, 2010
-
Charles River Laboratories to Report Guidance (Analyst Color, CRL, Price Target, Analyst Ratings / Fri, 09:57am)
